Browse Title Index

Issue Title
Vol 15, No 1 (2008) Chinese Medicine and Biomodulation in Cancer Patients (Part One) Abstract   PDF
Stephen M Sagar, Raimond K Wong
Vol 15, No 2 (2008) Chinese Medicine and Biomodulation in Cancer Patients (Part Two) Abstract   PDF
Stephen M Sagar, Raimond K Wong
Vol 19, No 3 (2012) Choices for young women at intermediate risk of breast cancer Details   PDF   HTML
J. Iqbal, S.A. Narod
Vol 24, No 3 (2017) Choosing wisely in cancer control across Canada—a set of baseline indicators Abstract   PDF   HTML
K. Tran, R. Rahal, S. Fung, G. Lockwood, C. Louzado, J. Xu, H. Bryant, in collaboration with the System Performance Steering Committee and Technical Working Group
Vol 18, No 2 (2011) Chronic lymphocytic leukemia and breast cancer as synchronous primary in a male a rare combination Details   PDF   HTML
B. Dubashi, A. Jain, K. Srinivasan, V. Surendrakumar, S. Vivekanandam
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer Abstract   PDF   HTML
M. Cabanero, M. Tsao
Vol 21, No 5 (2014) Clinical analysis of osteosarcoma patients treated with high-dose methotrexate-free neoadjuvant chemotherapy Abstract   PDF   HTML
M. Xu, S.F. Xu, X.C. Yu
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Clinical application and utility of genomic assays in early-stage breast cancer: key lessons learned to date Abstract   PDF   HTML
S.K.L. Chia
Vol 22, No 1 (2015) Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendations Abstract   PDF   HTML
M. Carrier, A. Lazo-Langner, S. Shivakumar, V. Tagalakis, P.L. Gross, N. Blais, C.A. Butts, M. Crowther
Vol 26, No 3 (2019) Clinical experience of patients referred to a multidisciplinary cardio-oncology clinic: an observational cohort study Abstract   PDF   HTML
C. Kappel, M. Rushton, C. Johnson, O. Aseyev, G. Small, A. Law, J. Ivars, S. Dent
Vol 19, No 5 (2012) Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution Abstract   PDF   HTML
K. Damiens, J.P.M. Ayoub, B. Lemieux, F. Aubin, W. Saliba, M. Campeau, Mustapha Tehfe
Vol 17, No 5 (2010) Clinical implications of next-generation sequencing for cancer medicine Abstract   PDF
A. Shuen, W.D. Foulkes
Vol 20, No 3 (2013) Clinical information available to oncologists in surgically treated rectal cancer: room to improve Abstract   PDF   HTML
G.A. Porter, R.L. Urquhart, D. Rheaume, S. Cwajna, M.A. Cox, E. Grunfeld
Vol 21, No 3 (2014) Clinical manifestations in patients with alpha-fetoprotein– producing gastric cancer Abstract   PDF   HTML
H.J. Lin, Y.H. Hsieh, W.L. Fang, K.H. Huang, A.F.Y. Li
Vol 20, No 1 (2013) Clinical outcomes of women with metastatic breast cancer treated with nab-paclitaxel: experience from a single academic cancer centre Abstract   PDF   HTML
S. Dent, J. Fraser, N. Graham, M. Campbell, S. Hopkins, G. Dranitsaris
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Clinical practice guidelines in breast cancer Abstract   PDF   HTML
N. Kumar Tyagi, S. Dhesy-Thind
Vol 24, No 4 (2017) Clinical results of accelerated hypofractionated radiotherapy for central-type small lung tumours Abstract   PDF   HTML
Y. Hatayama, M. Aoki, H. Kawaguchi, K. Hirose, M. Sato, H. Akimoto, M. Tanaka, I. Fujioka, K. Ichise, S. Ono, Y. Takai
Vol 26, No 2 (2019) Clinical significance of epithelial–mesenchymal transition–related molecules in lung adenocarcinoma Abstract   PDF   HTML
Y. Zhang, L. F. Wang, J. H. Gao, L. Li, P. Jiang, X. Lv, L. X. Yu, J. Yang, R. T. Li, B. R. Liu
Vol 23, No 5 (2016) Clinical surveillance compared with clinical and magnetic resonance imaging surveillance for brain metastasis: a feasibility survey Abstract   PDF   HTML
K.C.Y. Yiu, J.N. Greenspoon
Vol 26, No 1 (2019) Clinical trial implications for study participants accessing medical assistance in dying Abstract   PDF   HTML
B. Henry, S. Bean, Y. J. Ko, D. Selby
Vol 24, No 5 (2017) Clinical utility of multigene profiling assays in early-stage breast cancer Abstract   PDF   HTML
M.C. Chang, L.H. Souter, S. Kamel-Reid, M. Rutherford, P. Bedard, M. Trudeau, J. Hart, A. Eisen, and the Molecular Oncology Advisory Committee
Vol 24, No 2 (2017) Clinician participation in CADTH’s pan-Canadian Oncology Drug Review: contribution and impact on cancer drug funding recommendations Abstract   PDF   HTML
M. Trudeau, P. Hoskins, T. Reiman, A. Chambers, H. Mai, P. Wheatley-Price
Vol 16, No 6 (2009) Clinician-patient communication: evidence-based recommendations to guide practice in cancer Abstract   PDF
G. Rodin, C. Zimmermann, C. Mayer, D. Howell, M. Katz, J. Sussman, J. Mackay, M. Brouwers
Vol 19, No 6 (2012) Clinicopathologic characteristics and survival outcomes of patients with advanced esophageal, gastroesophageal junction, and gastric adenocarcinoma: a single-institution experience Abstract   PDF   HTML
A. Dechaphunkul, K. Mulder, F. El-Gehani, S. Ghosh, J. Deschenes, J. Spratlin
Vol 18, No 4 (2011) CML biology for the clinician in 2011: six impossible things to believe before breakfast on the way to cure Abstract   PDF   HTML
B. Leber
2008: Presentations from the Integrating Wellness into Cancer Care Conference CMO Macmillan Cancer Support National lead follow up & survivorship Abstract   PPT Presentation
Jane Maher
Vol 23, No 2 (2016) Collaborative case conferences in rectal cancer: case series in a tertiary care centre Abstract   PDF   HTML
C. Eskicioglu, S. Forbes, S. Tsai, V. Francescutti, A. Coates, V. Grubac, R. Sonnadara, M. Simunovic
Vol 16, No 6 (2009) Colorectal Cancer Association of Canada Consensus Meeting on Practice Guidelines - Raising the Standard of Care in Canada for Early Stage Rectal Cancer Abstract   PDF
The Colorectal Cancer Association of Canada
Vol 20, No 5 (2013) Colorectal cancer screening in Canada: results from the first round of screening for five provincial programs Abstract   PDF   HTML
D. Major, H. Bryant, M. Delaney, S. Fekete, L. Gentile, M. Harrison, V. Mai, E. Nicholson, Y. Taylor, on behalf of the Colorectal Cancer Screening Monitoring Program Performance Working Group and the Canadian Partnership Against Cancer
Vol 19 (2012): Oncology in China Combined performance of physical examination, mammography, and ultrasonography for breast cancer screening among Chinese women: a follow-up study Abstract   PDF   HTML
Y. Huang, M. Kang, H. Li, J.Y. Li, J.Y. Zhang, L.H. Liu, X.T. Liu, Y. Zhao, Q. Wang, C.C. Li, H. Lee
Vol 23, No 5 (2016) Combined sorafenib and yttrium-90 radioembolization for the treatment of advanced hepatocellular carcinoma Abstract   PDF   HTML
A. Salman, E. Simoneau, M. Hassanain, P. Chaudhury, L.M. Boucher, D. Valenti, T. Cabrera, C. Nudo, P. Metrakos
Vol 17, No 5 (2010) Combining radiation therapy and androgen deprivation for localized prostate cancer—a critical review Abstract   PDF
A. Dal Pra, F.L. Cury, L. Souhami
Vol 24, No 5 (2017) Coming of age in Canada: a study of population-based genetic testing for breast and ovarian cancer Abstract   PDF   HTML
M.R. Akbari, N. Gojska, S.A. Narod
Vol 20, No 3 (2013) Comment on “Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution” Abstract   PDF   HTML
D. Bernardi, O. Tomassi, M. Stefani, A. Di Giacobbe
Vol 24, No 4 (2017) Communication and informed consent ... a story Abstract   PDF   HTML
E. Aitini
Vol 16, No 2 (2009) Community Based Organizations are critical partners in providing complete cancer care Abstract   PDF
Robert Rutledge
Vol 23, No 4 (2016) Comparative efficacy of whole-brain radiotherapy with and without elemene liposomes in patients with multiple brain metastases from non-small-cell lung carcinoma Abstract   PDF   HTML
Y.N. Sun, Z.Y. Zhang, Y.C. Zheng, F. Chi, X.Y. Jin, R. Wu
Vol 24, No 2 (2017) Comparative survival in patients with brain metastases from non-small-cell lung cancer treated before and after implementation of radiosurgery Abstract   PDF   HTML
J.N. Greenspoon, P.M. Ellis, G. Pond, S. Caetano, J. Broomfield, A. Swaminath
Vol 22, No 3 (2015) Comparing effectiveness with efficacy: outcomes of palliative chemotherapy for non-small-cell lung cancer in routine practice Abstract   PDF   HTML
L.D. Harrison, J. Zhang-Salomons, M. Mates, C.M. Booth, W.D. King, W.J. Mackillop
Vol 25, No 3 (2018) Comparing enrolees with non-enrolees of cancer-patient navigation at end of life Abstract   PDF   HTML
G. Park, G.M. Johnston, R. Urquhart, G. Walsh, M. McCallum
Vol 13, No 5 (2006) Comparing The Results Of Bisphosphonate Use In Clinical Trials With Actual Practice: Abstract   PDF
Mary C Gainford, George Dranitsaris, Wei S Ooi, Marie Vanhuyse, Mark Clemons
Vol 19, No 3 (2012) Comparison of international breast cancer guidelines: are we globally consistent? Cancer Guideline AGREEment Abstract   PDF   HTML
S. Hogeveen, D. Han, S. Trudeau-Tavara, J. Buck, C.B. Brezden-Masley, M.L. Quan, C.E. Simmons
Vol 20, No 6 (2013) Comparison of recurrence and survival rates after breast-conserving therapy and mastectomy in young women with breast cancer Abstract   PDF   HTML
J.Q. Cao, R.A. Olson, S.K. Tyldesley
Vol 25, No 4 (2018) Complementary and alternative medicine use in patients before and after a cancer diagnosis Abstract   PDF   HTML
C.A. Buckner, R.M. Lafrenie, J.A. Dénommée, J.M. Caswell, D.A. Want
Vol 17, No 5 (2010) Complete response of hepatocellular carcinoma with sorafenib and 90Y radioembolization Abstract   PDF
P.K. Chaudhury, M. Hassanain, J.M. Bouteaud, T. Alcindor, C.G. Nudo, D. Valenti, T. Cabrera, P. Kavan, I. Feteih, P. Metrakos
Vol 25, No 1 (2018) Completing the cervical screening pathway: Factors that facilitate the increase of self-collection uptake among under-screened and never-screened women, an Australian pilot study Abstract   PDF   HTML
E. McLachlan, S. Anderson, D. Hawkes, M. Saville, K. Arabena
Vol 25, No 3 (2018) Comprehensive metastatic lung cancer care must include palliative care Abstract   PDF   HTML
A.M. Rosenblum, M. Chasen
Vol 22, No 3 (2015) Computed tomography–based distribution of involved lymph nodes in patients with upper esophageal cancer Abstract   PDF   HTML
M. Li, Y. Liu, L. Xu, Y. Huang, W. Li, J. Yu, L. Kong
Vol 25, No 5 (2018) Computed tomography–quantified body composition predicts short-term outcomes after gastrectomy in gastric cancer Abstract   PDF   HTML   Supplemental Material
Y. Zhang, J. P. Wang, X. L. Wang, H. Tian, T. T. Gao, L. M. Tang, F. Tian, J. W. Wang, H. J. Zheng, L. Zhang, X. J. Gao, G. L.. Li, X. Y. Wang
Vol 21, No 4 (2014) Computerized prescriber order entry in the outpatient oncology setting: from evidence to meaningful use Abstract   PDF   HTML
V. Kukreti, R. Cosby, A. Cheung, S. Lankshear, ST Computerized Prescriber Order Entry Guideline Development Group
Vol 16, No 2 (2009) Concomitant renal cell carcinoma and chronic myelogenous leukemia: use of a targeted approach Details   PDF
Sumanta K Pal, Ravi K Gupta, Gary Dosik, Robert A Figlin
Vol 21, No 3 (2014) Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study Abstract   PDF   HTML
Z. Liang, X. Zhu, L. Li, S. Qu, X. Liang, Z. Liang, F. Su, Y. Li, W. Zhao
Vol 22, No 1 (2015) Concurrent chemoradiotherapy for locally advanced breast cancer—time for a new paradigm? Abstract   PDF   HTML
V. Mandilaras, N. Bouganim, J. Spayne, R. Dent, A. Arnaout, J.F. Boileau, M. Brackstone, S. Meterissian, M. Clemons
Vol 23, No 4 (2016) Concurrent hypopituitarism and leukemic retinopathy in a child with B-precursor acute lymphoblastic leukemia and isolated central nervous system relapse Abstract   PDF   HTML
K.H. Wu, H.P. Wu, H.J. Lin, C.H. Wang, H.Y. Chen, T. Weng, C.T. Peng, Y.H. Chao
Vol 26, No 1 (2019) Conditional approval of cancer drugs in Canada: accountability and impact on public funding Abstract   PDF   HTML   Supplemental Material
S. K. Andersen, N. Penner, A. Chambers, M. E. Trudeau, K. K.W. Chan, M. C. Cheung
Vol 24, No 5 (2017) Conditional survival after a diagnosis of malignant brain tumour in Canada: 2000–2008 Abstract   PDF   HTML
Y. Yuan, J. Ross, Q. Shi, F.G. Davis
Vol 19, No 4 (2012) Conditional survival in Canada: adjusting patient prognosis over time Abstract   PDF   HTML
H. Bryant, G. Lockwood, R. Rahal, L. Ellison
Vol 25, No 6 (2018) Conflict of interest: “Be rigorous in judging ourselves and gracious in judging others” Abstract   PDF   HTML
B. Basulaiman, A. Awan, J. F. Hilton, M. Clemons
Vol 25, No 2 (2018) Connecting people with cancer to physical activity and exercise programs: a pathway to create accessibility and engagement Abstract   PDF   HTML
D. Santa Mina, C.M. Sabiston, D. Au, A.J. Fong, L.C. Capozzi, D. Langelier, M. Chasen, J. Chiarotto, J.R. Tomasone, J.M. Jones, E. Chang, S.N. Culos-Reed
Vol 20, No 1 (2013) Consensus recommendations for cancer rehabilitation: research and education priorities Abstract   PDF   HTML
S. McEwen, M. Egan, M. Chasen, M. Fitch
Vol 17, No 3 (2010) Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian national expert group Abstract   PDF
W. Kocha, J. Maroun, H. Kennecke, C. Law, P. Metrakos, J. F. Ouellet, R. Reid, C. Roswell, A. Shah, S. Singh, S. Van Uum, R. Wong
Vol 17, No 6 (2010) Consensus recommendations for the use of anti-EGFR therapies in metastatic colorectal cancer Abstract   PDF
C. Cripps, S. Gill, S. Ahmed, B. Colwell, S. Dowden, H. Kennecke, J. Maroun, B. Samson, M. Thirlwell, R. Wong
Vol 22, No 2 (2015) Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5–6, 2014 Abstract   PDF   HTML
S. Ahmed, O. Bathe, S. Berry, D. Buie, J. Davies, C. Doll, S. Dowden, S. Gill, V. Gordon, P. Hebbard, E. Jones, H. Kennecke, S. Koski, M. Krahn, D. Le, H. Lim, C. Lund, Y. Luo, A. Mcffadden, J. Mcghie, K. Mulder, J. Park, F. Rashidi, A. Sami, J. Tan, R. Wong
Vol 18, No 4 (2011) Consensus-based nutritional recommendations for patients with head-and-neck cancer Details   PDF   HTML
E. Isenring
Vol 17, No 6 (2010) Consent to external-beam radiotherapy Abstract   PDF
C. Freeman, H. Lamed, C. Gingras, G. Shenouda
Vol 20, No 1 (2013) Conservative management for an entero-adnexal fistula at initial presentation of advanced ovarian carcinoma Abstract   PDF   HTML
A. Shai, E. Grikshtas, Y. Segev, Moshe Moskovitz, A. Bitterman, M. Steiner, O. Lavie
Vol 16, No 4 (2009) Conservative Treatment of Invasive Bladder Cancer Abstract   PDF
Luis Souhami, Nicholas Rene, Fabio Biagini Cury
Vol 24, No 2 (2017) Consultative workshop proceedings of the Canadian Team to Improve Community-Based Cancer Care Along the Continuum Abstract   PDF   HTML
E. Grunfeld, B. Petrovic, for the CanIMPACT investigators
Vol 15, No 4 (2008) Contemporary Management of Stage I Testicular Seminoma: A Survey of Canadian Abstract   PDF
Rajiv S Samant, Ibraheem Alomary, Paul Genest, Libni Eapen
Vol 24, No 2 (2017) Contextualizing the use of oncologic imaging within treatment phases: imaging trends and modality preferences, 2000–2014 Abstract   PDF   HTML
T.P. Copeland, J.M. Creasman, D.J. Seidenwurm, B.L. Franc
Vol 20, No 3 (2013) Continued success in providing timely palliative radiation therapy at the Rapid Response Radiotherapy Program: a review of 2008–2012 Abstract   PDF   HTML
N. Thavarajah, K. Wong, L. Zhang, G. Bedard, E. Wong, M. Tsao, C. Danjoux, E. Barnes, A. Sahgal, K. Dennis, L. Holden, N. Lauzon, E. Chow
Vol 19, No 5 (2012) Continuity clinics in oncology training programs in Canada Abstract   PDF   HTML
J.M. Croke, M.M. Vickers, C. E, D.Y. Heng, M.N. Reaume, X. Song, J. Meng, T. Asmis, C. Lochrin
Vol 25, No 6 (2018) Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact Abstract   PDF   HTML
A. Bouchard-Fortier, N. N. Baxter, R. Sutradhar, K. Fernandes, X. Camacho, P. Graham, M. L. Quan
Vol 23, No 6 (2016) Controlled settings for lung cancer screening: why do they matter? Considerations for referring clinicians Abstract   PDF   HTML
A. Bharmal, A. Crosskill, S. Lam, H. Bryant
Vol 24, No 5 (2017) Coordination of radiologic and clinical care reduces the wait time to breast cancer diagnosis Abstract   PDF   HTML
E.C. McKevitt, C.K. Dingee, R. Warburton, J.S. Pao, C.J. Brown, C. Wilson, U. Kuusk
Vol 18, No 3 (2011) Cord stem-cell transplantation in Ontario: do we need a public bank? Abstract   PDF   HTML
A. Gassas
Vol 15, No 2 (2008) Coriolus versicolor extracts: clinical relevance in cancer management Abstract   PDF
Maria OP Szeto
Vol 21, No 2 (2014) Corrigendum: A Canadian perspective on the safe administration of bendamustine and the prevention and management of adverse events Abstract   PDF   HTML
J. Koolwine, T. Crosbie, G. Gazzé, R. Turner, J. Wiernikowski, W. Assaily
Vol 20, No 1 (2013) Corrigendum: A first look at participation rates in cervical cancer screening programs in Canada Details   PDF   HTML
Current Oncology
Vol 19, No 3 (2012) Corrigendum: A personalized approach to treatment: use of EGFR tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in Canada Details   PDF   HTML
V. Hirsh, B. Melosky, G. Goss, D. Morris, W. Morzycki
Vol 23, No 5 (2016) Corrigendum: Did the addition of concomitant chemotherapy to radiotherapy improve outcomes in hypopharyngeal cancer? A population-based study Abstract   PDF   HTML
S.F. Hall, R. Griffiths
Vol 23, No 4 (2016) Corrigendum: Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014 Abstract   PDF   HTML
E. Tsvetkova, S. Sud, N. Aucoin, J. Biagi, R. Burkes, B. Samson, S. Brule, C. Cripps, B. Colwell, C. Falkson, M. Dorreen, R. Goel, F. Halwani, C. Marginean, C. Marginean, J. Maroun, N. Michaud, M. Tehfe, M. Thirlwell, M. Vickers, T. Asmis
Vol 18, No 6 (2011) Corrigendum: Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective Abstract   PDF   HTML
A. Oza
Vol 19, No 1 (2012) Corrigendum: Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba Abstract   PDF   HTML
Current Oncology
Vol 20, No 3 (2013) Corrigendum: Ubiquitin pathway and ovarian cancer Abstract   PDF   HTML
Z. Rao, Y. Ding
Vol 24, No 5 (2017) Cost analysis of breast cancer diagnostic assessment programs Abstract   PDF   HTML
G.N. Honein-AbouHaidar, J.S. Hoch, M.J. Dobrow, T. Stuart-McEwan, D.R. McCready, A.R. Gagliardi
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis Abstract   PDF   HTML
I. Cromwell, Z. Ferreira, L. Smith, K. van der Hoek, G. Ogilvie, A. Coldman, S.J. Peacock
Vol 17, No 1 (2010) Cost effectiveness of TAC versus FAC in adjuvant treatment of node-positive breast cancer Abstract   PDF
N. Mittmann, S. Verma, M. Koo, K. Alloul, M. Trudeau
Vol 23, No 3 (2016) Cost impact analysis of Enhanced Recovery After Surgery program implementation in Alberta colon cancer patients Abstract   PDF   HTML
G. Nelson, L.N. Kiyang, A. Chuck, N.X. Thanh, L.M. Gramlich
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Cost implications of unwarranted imaging for distant metastasis in women with early-stage breast cancer in Ontario Abstract   PDF   HTML
K. Thavorn, Z. Wang, D. Fergusson, S. van Katwyk, A. Arnaout, M. Clemons
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Cost trajectories for cancer patients Abstract   PDF   HTML
W.P Wodchis, E. Arthurs, A.I. Khan, S. Gandhi, M. MacKinnon, J. Sussman
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Cost-effectiveness analysis of whole-mount pathology processing for patients with early breast cancer undergoing breast conservation Abstract   PDF   HTML
N.J. Look Hong, G.M. Clarke, M.J. Yaffe, C.M.B. Holloway
Vol 21, No 1 (2014) Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes Abstract   PDF   HTML
A.R. Levy, D. Zou, N. Risebrough, R. Buckstein, T. Kim, N. Brereton
Vol 25, No 1 (2018) Cost-effectiveness of everolimus for the treatment of advanced neuroendocrine tumours of gastrointestinal or lung origin in Canada Abstract   PDF   HTML
A. Chua, A. Perrin, J.F. Ricci, M.P. Neary, M. Thabane
Vol 21, No 4 (2014) Cost-effectiveness of first-line treatments for patients with KRAS wild-type metastatic colorectal cancer Abstract   PDF   HTML
E.M. Ewara, G.S. Zaric, S. Welch, S. Sarma
Vol 21, No 1 (2014) Cost-effectiveness of FOLFIRINOX for first-line treatment of metastatic pancreatic cancer Abstract   PDF   HTML
C.L. Attard, S. Brown, K. Alloul, M.J. Moore
Vol 20, No 5 (2013) Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor–positive metastatic breast cancer in Canada Abstract   PDF   HTML
T.E. Delea, J. Amdahl, A. Chit, M.M. Amonkar
Vol 17, No 1 (2010) Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada Abstract   PDF
C.L. Attard, J.A. Maroun, K. Alloul, D.T. Grima, L.M. Bernard
Vol 23, No 4 (2016) Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada Abstract   PDF   HTML
J. Amdahl, J. Diaz, J. Park, H.R. Nakhaipour, T.E. Delea
Vol 21, No 6 (2014) Cost-effectiveness of pazopanib in advanced soft-tissue sarcoma in Canada Abstract   PDF   HTML
T.E. Delea, J. Amdahl, H.R. Nakhaipour, S.C. Manson, A. Wang, N. Fedor, A. Chit
301 - 400 of 1658 Items << < 1 2 3 4 5 6 7 8 9 10 > >>